Death Of Bhopal Volunteer Not Due To Covaxin: Bharat BioTech
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Bharat BioTech said that the death of a 42-year-old volunteer from Bhopal, who was allegedly administered a dose of its COVID vaccine, Covaxin, in a clinical trial, was not related to the vaccine or placebo.

In a statement, the company noted that with regard to reports of a death in Phase III trials, we would like to state that a volunteer passed away on December 21, 2020. He had fulfilled all the criteria to be accepted as a participant in the Phase III trial and was reported to be healthy in all the site follow up calls post seven days of his dosing and no AE’s were observed or reported.

As per the post-mortem report, the probable cause of death was due to cardiorespiratory failure as a result of suspected poisoning and the case is under police investigation as well. The volunteer passed away nine days after the dosing and preliminary reviews by the site indicate that the death is unrelated to the study dosing. “We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded,” the statement said.

“There are several factors that can cause an adverse event during a clinical trial, including the patient’s underlying disease, other pre-existing conditions, or any other unrelated occurrence like an accident,” Bharat BioTech said.

Source:
https://www.thehindu.com/news/national/coronavirus-death-of-bhopal-covaxin-volunteer-not-due-to-vaccine-says-bharat-biotech/article33538623.ece
Dr. J●●●●●e B●●●●●i and 6 others like this2 shares
Like
Comment
Share